proteom
larg
scale
analysi
protein
feasibl
thank
avail
differ
technolog
mass
spectrometri
gelbas
techniqu
antibodybas
array
recent
develop
aptamerbas
technolog
despit
technolog
improv
extract
knowledg
data
produc
still
challeng
develop
data
analysi
workflow
capabl
provid
addit
insight
compar
tradit
method
would
highli
advantag
particular
first
desir
outcom
identif
accur
diagnost
prognost
marker
suitabl
subject
stratif
would
shorten
path
applic
precis
medicin
concept
clinic
practic
anoth
highli
desir
outcom
better
understand
diseas
basi
newli
avail
proteom
profil
second
aim
system
biolog
approach
base
network
analysi
would
enabl
integr
highli
descript
diseas
biomark
exist
knowledg
potenti
provid
addit
insight
affect
biolog
process
work
introduc
approach
achiev
aim
use
recent
publish
proteom
data
obtain
duchenn
muscular
dystrophi
dmd
cohort
dmd
rare
diseas
caus
mutat
gene
encod
dystrophin
main
clinic
featur
observ
dmd
patient
presenc
muscular
damag
coupl
chronic
inflamm
lead
progress
muscular
degener
fibrosi
averag
age
diagnosi
usual
fourfiv
year
symptom
appear
disabl
start
aris
avail
diseas
biomark
assess
use
simpl
noninvas
techniqu
would
use
better
understand
biolog
pathway
alter
diseas
could
use
earli
diagnosi
second
end
serum
creatin
kinas
ck
level
usual
evalu
howev
blood
ck
concentr
show
high
variabl
influenc
age
child
physic
activ
extent
pharmacolog
treatment
studi
employ
optim
version
rankbas
classif
algorithm
introduc
identifi
two
biomark
panel
base
somalog
profil
dmd
patient
control
character
classif
perform
use
panel
start
point
analysi
aim
identifi
biolog
pathway
alter
diseas
circumv
limit
repres
rel
short
list
protein
measur
blood
somalog
array
resort
networkbas
system
biolog
approach
identifi
list
biolog
process
affect
dmd
therefor
first
contribut
studi
identif
accur
diagnost
prognost
marker
suitabl
subject
stratif
anoth
contribut
better
understand
diseas
term
pathway
identifi
affect
basi
alter
serum
proteom
profil
built
workflow
base
biomark
discoveri
algorithm
tool
network
analysi
recent
develop
fig
biomark
discoveri
algorithm
identifi
subjectspecif
list
protein
herein
call
signatur
compar
order
classifi
subject
belong
one
two
class
affect
control
aggreg
individu
signatur
produc
list
protein
use
subject
classif
refer
biomark
panel
sinc
method
tune
obtain
panel
differ
length
appli
twice
differ
set
obtain
two
biomark
panel
shown
fig
shorter
one
obtain
specif
classif
purpos
longer
one
deriv
identifi
biolog
process
affect
diseas
specif
use
protein
long
biomark
panel
input
networkbas
tool
nasfind
identifi
function
modul
subnetwork
connect
biomark
protein
known
transcript
factor
identifi
biomark
panel
associ
dmd
analyz
concentr
level
blood
protein
obtain
use
somascan
technolog
cohort
case
control
parent
project
muscular
dystrophycincinnati
children
hospit
medic
centr
studi
see
detail
materi
method
overal
determin
individu
signatur
form
two
protein
panel
six
satisfactori
discrimin
dmd
patient
control
perfect
accuraci
averag
crossvalid
round
permut
test
pvalu
six
protein
epitop
correspond
follow
gene
ckbckm
fgg
tabl
princip
compon
analysi
perform
dataset
contain
data
six
protein
confirm
separ
dmd
patient
control
accord
main
axi
variat
fig
contribut
protein
achiev
controlaffect
classif
illustr
fig
heatmap
measur
protein
level
show
singl
protein
level
highli
correl
partit
subject
two
group
fig
signatur
length
two
select
method
inclus
short
panel
fig
red
box
suffici
correctli
identifi
controlaffect
statu
individu
intermedi
step
algorithm
comput
complet
distanc
matrix
base
similar
pair
subject
signatur
shown
form
heatmap
fig
aid
interpret
distanc
matrix
map
subject
drawn
use
shortest
n
distanc
color
ad
afterward
accord
controlaffect
statu
case
map
clearli
show
emerg
two
welldefin
group
subject
perfectli
segreg
diseas
statu
fig
six
protein
relat
differ
fundament
aspect
diseas
particular
serum
creatin
kinas
marker
muscular
damag
known
long
time
increas
dmd
patient
even
dmdspecif
similarli
carbon
anhydras
anoth
indic
muscular
damag
highli
express
skelet
muscl
also
troponin
protein
involv
regul
muscl
contract
found
blood
prolong
exercis
addit
protein
muscl
origin
biomark
panel
includ
encod
regul
complement
cascad
togeth
fibrinogen
cadherin
like
involv
fibrosi
dmd
hallmark
despit
use
six
protein
biomark
panel
classif
purpos
show
limit
applic
understand
pathway
alter
diseas
sinc
key
aspect
diseas
could
identifi
specul
longer
list
would
like
highlight
set
impair
pathway
statist
signific
way
reason
train
classif
algorithm
use
differ
set
obtain
longest
protein
list
allow
classif
accuraci
close
identifi
protein
abl
discrimin
diseas
healthi
control
accuraci
predict
permut
test
pvalu
tabl
evalu
biolog
role
protein
first
analyz
tissuespecif
express
use
transcript
express
level
human
protein
atla
hpa
dataset
analysi
identifi
eleven
protein
biomark
tissu
specif
hpa
among
highlight
overrepresent
musclespecif
protein
fig
tabl
fact
skelet
muscl
result
significantli
enrich
tissu
pvalu
fisher
exact
test
five
protein
show
specif
express
carbon
anhydras
creatin
kinas
mtype
ckm
mitogenactiv
protein
kinas
tropomyosin
beta
chain
troponin
fasttwitch
isoform
addit
biomark
includ
one
protein
specif
heart
muscl
cardiac
troponin
four
protein
despit
tissu
specif
show
elev
express
group
group
enrich
includ
skelet
heart
muscl
camkii
subunit
alpha
camkii
subunit
beta
hearttyp
fatti
acidbind
protein
myoglobin
mb
notabl
biomark
also
show
overrepresent
liverspecif
protein
pvalu
fisher
exact
test
sinc
serum
protein
level
dmd
patient
known
affect
age
investig
protein
biomark
panel
chang
accord
age
patient
verifi
age
distribut
patient
significantli
differ
control
pvalu
kolmogorovsmirnov
test
fig
test
presenc
relationship
age
protein
level
identifi
protein
whose
serum
level
chang
significantli
age
top
protein
shown
fig
full
list
biomark
protein
shown
fig
tabl
two
except
case
protein
level
decreas
age
dmd
patient
remain
stabl
control
nine
show
signific
agerel
chang
also
control
variat
observ
two
group
differ
affect
separ
fig
result
unexpect
sinc
diseas
known
affect
protein
level
along
progress
chang
relat
progress
loss
muscl
mass
given
presenc
cohort
dmd
subject
treat
steroid
check
treatment
influenc
protein
level
protein
biomark
panel
result
significantli
associ
treatment
indic
protein
potenti
affect
drug
fig
despit
presenc
dataset
patient
treat
steroid
patient
treat
affect
classif
fig
identifi
biolog
process
alter
diseas
first
comput
overlap
biomark
protein
gene
set
retriev
msigdb
specif
gene
set
enrich
analysi
perform
use
hallmark
gene
set
canon
pathway
kegg
reactom
biocarta
tabl
analysi
hallmark
gene
set
confirm
overrepresent
skelet
muscl
protein
signific
enrich
myogenesi
gene
set
bh
correct
pvalu
gene
code
biomark
protein
present
myogenesi
gene
set
ckm
gsn
mb
ckb
addit
musclerel
biolog
function
biocarta
pathway
analysi
reveal
presenc
protein
involv
coagul
cascad
point
presenc
differ
signal
pathway
differenti
regul
dmd
individu
compar
control
tabl
particular
significantli
enrich
biocarta
pathway
includ
differ
gene
set
relat
insulin
pathway
pathway
akt
pathway
pathway
consist
alreadi
describ
role
muscl
atrophi
hypertrophi
next
step
analysi
investig
presenc
deregul
regulatori
circuit
dmd
use
networkbas
approach
workflow
appli
nasfind
network
analysi
tool
recent
develop
specif
map
global
signal
interact
network
protein
biomark
panel
identifi
subnetwork
connect
protein
transcript
factor
tf
opt
use
tf
sourc
node
top
signal
regulatori
cascad
connect
tf
protein
interest
establish
nasfind
preferenti
differenti
express
protein
see
detail
materi
method
identifi
biolog
process
associ
diseas
regulatori
circuit
perform
networkbas
pathway
enrich
analysi
signific
pathway
report
tabl
togeth
transcript
factor
nasfind
identifi
probabl
regul
whole
result
gene
set
partial
overlap
shown
fig
tabl
suggest
presenc
share
regul
biolog
process
involv
multipl
pathway
inde
myogenesi
show
gene
common
pathway
confirm
peculiar
transcript
factor
select
put
regul
transcript
activ
specif
muscl
gene
enrich
map
interest
observ
central
biocarta
bad
pathway
gene
set
relat
regul
proapoptot
molecul
bad
among
regul
subnetwork
forkhead
famili
transcript
factor
repres
member
respect
identifi
regul
subnetwork
enrich
gene
involv
acut
myocardi
infarct
pathway
cancer
pathway
neurotrophin
signal
immun
system
pathway
particular
eleven
protein
nasfind
subnetwork
present
neurotrophin
pathway
pvalu
x
seven
correspond
gene
faslg
deriv
biomark
other
ad
nasfind
basi
differenti
express
protein
interest
observ
protein
code
gene
also
identifi
reactom
immun
system
pathway
pvalu
consid
subnetwork
relat
pathway
pinpoint
nasfind
subunit
alpha
regulatori
subunit
alpha
identifi
protein
share
among
pathway
except
myogenesi
myocardi
infarct
two
protein
subunit
phosphatidylinositol
key
element
pathway
regul
sever
signal
cascad
particular
foxo
signal
investig
relev
identifi
pathway
diseas
biolog
evalu
close
interactom
protein
belong
pathway
describ
dystrophin
protein
mutat
diseas
expect
pathway
protein
necessarili
involv
diseas
calcul
shortest
path
distanc
dystrophin
pathway
protein
among
nine
pathway
identifi
use
networkbas
pathway
enrich
analysi
tabl
neurotrophin
signal
pathway
result
significantli
closer
dmd
expect
chanc
empir
pvalu
fig
result
offer
networkbas
support
involv
signal
cascad
specif
signal
diseas
select
five
publish
proteom
studi
perform
blood
serum
subject
affect
dmd
dmd
mous
model
check
protein
panel
alreadi
describ
dmd
biomark
tabl
twentyseven
protein
includ
long
biomark
panel
alreadi
identifi
differenti
present
serum
dmd
case
compar
control
previou
analysi
perform
hathout
collabor
assess
similar
result
two
studi
investig
protein
signatur
analysi
workflow
use
gene
set
enrich
analysi
although
none
signific
multipl
test
correct
enrich
pathway
share
two
studi
see
tabl
use
nasfind
analysi
identifi
statist
signific
pathway
tabl
interestingli
three
immun
system
hemostasi
myogenesi
share
analysi
myogenesi
transcript
factor
identifi
close
regul
compar
result
studi
ayoglu
collabor
perform
antibodi
bead
array
platform
creatin
kinas
carbon
anidras
protein
common
long
panel
gsn
alreadi
pinpoint
mass
spectrometri
analysi
human
serum
cynthia
martin
et
al
comparison
also
includ
two
studi
perform
use
dmd
mous
model
case
nine
protein
common
studi
use
somascan
technolog
proteom
profil
five
protein
studi
base
mass
spectrometri
serum
proteom
detect
protein
present
blood
howev
deriv
muscl
degener
fiber
releas
system
circul
rather
reflect
express
regul
base
consider
decid
analyz
type
evid
complementari
proteom
data
specif
select
public
dataset
genomewid
express
data
obtain
skelet
muscl
dmd
control
dataset
contain
express
data
quadricep
patient
clinic
symptom
consist
dmd
diagnosi
whose
biopsi
shown
dystrophin
defici
calcul
differenti
express
gene
investig
biolog
process
affect
pathway
enrich
analysi
perform
use
differenti
express
gene
input
evalu
overlap
pathway
identifi
nasfind
except
two
biocarta
gene
set
pathway
identifi
nasfind
proteom
dataset
result
significantli
enrich
report
tabl
evalu
dysregul
pathway
dataset
dmd
patient
earli
phase
diseas
control
data
allow
us
test
dysregul
pathway
presymptomat
phase
diseas
except
biocarta
gene
set
pathway
result
among
top
result
tabl
studi
adopt
system
biolog
approach
studi
duchenn
muscular
dystrophi
workflow
base
combin
two
complementari
methodolog
biomark
identif
network
analysi
appli
algorithm
biomark
identif
point
essenti
featur
biolog
system
ie
minimum
set
protein
abl
fulli
separ
healthi
affect
subject
appli
network
analysi
unravel
complex
interact
among
protein
take
advantag
flexibl
algorithm
calcul
two
differ
protein
list
short
one
long
one
protein
present
short
biomark
panel
alreadi
describ
dmd
biomark
hathout
et
al
relat
main
patholog
featur
observ
dmd
howev
short
biomark
panel
describ
compar
signatur
hathout
et
al
advantag
abl
classifi
subject
six
protein
achiev
perfect
accuraci
high
statist
signific
permut
test
pvalu
long
biomark
panel
size
compar
diseas
signatur
report
hathout
et
al
vs
protein
respect
approxim
half
protein
common
two
list
low
overlap
surpris
view
fact
differ
approach
use
two
studi
classificationori
vs
statist
signific
shown
equival
investig
point
view
classificationori
list
provid
addit
insight
less
known
aspect
diseas
pathophysiolog
particular
identifi
deregul
pathway
potenti
regul
inde
addit
protein
muscl
origin
like
found
serum
proteom
consequ
sarcolemma
leakag
analysi
point
sever
protein
involv
cell
signal
given
biolog
role
surpris
detect
blood
serum
result
line
grow
evid
suggest
cellular
structur
instabl
caus
lack
dystrophin
affect
differ
signal
pathway
particular
networkbas
pathway
enrich
analysi
implement
nasfind
identifi
nine
pathway
significantli
enrich
among
influenti
node
differ
transcript
factor
belong
foxo
famili
identifi
possibl
regul
human
foxo
protein
express
skelet
muscl
implic
muscl
homeostasi
specif
regard
muscl
mass
foxo
protein
shown
enhanc
proteolysi
ubiquitinproteasom
autophagylysosom
system
notabl
studi
sarcopenia
physiolog
agerel
loss
muscl
mass
identifi
upregul
gene
muscl
old
subject
anoth
studi
found
increas
mrna
age
muscl
howev
find
recent
studi
suggest
sarcopenia
due
foxo
activ
highlight
need
studi
better
understand
role
foxo
protein
physiolog
patholog
muscl
condit
among
subnetwork
regul
foxo
protein
neurotrophin
signal
pathway
cascad
biolog
process
regul
cell
surviv
apoptosi
identifi
enrich
analysi
although
neurotrophin
mainli
link
nervou
system
recent
studi
indic
involv
skelet
muscl
adapt
regener
specif
experiment
evid
show
neurotrophin
involv
muscl
regener
dystroph
mice
nerv
growth
factor
paradigm
neurotrophin
famili
identifi
muscl
patient
affect
dmd
interestingli
recent
studi
perform
use
mdx
mous
model
dmd
link
apoptosi
myofib
presenc
connexin
protein
channel
involv
activ
ino
express
apoptot
cell
death
analysi
dna
bind
subunit
nfkb
protein
complex
present
subnetwork
defin
nasfind
protein
part
neurotrophinrel
signal
network
proxim
analysi
fig
suggest
dysregul
neurotrophin
signal
pathway
patient
affect
dmd
might
mediat
fa
ligand
faslg
mediat
cellular
apoptot
signal
direct
interactor
dystrophin
protein
link
duchenn
muscular
dystrophi
faslg
alreadi
report
abdelsalam
et
al
observ
significantli
increas
level
faslg
mrna
express
blood
dmd
patient
compar
control
addit
neurotrophin
signal
analysi
point
among
foxorel
subnetwork
enrich
immun
system
signal
identifi
regul
role
foxo
protein
immun
system
alreadi
describ
interestingli
process
togeth
hemostasi
anoth
signific
pathway
nasfind
analysi
key
player
fibrosi
promin
featur
dystroph
muscl
thu
conceiv
dysregul
blood
protein
belong
pathway
consequ
fibrot
process
ongo
muscl
dmd
patient
notabl
modul
immun
respons
suggest
potenti
mean
allevi
diseas
intens
foxo
transcript
factor
pathway
enrich
subnetwork
case
two
pathway
result
enrich
biocarta
acut
myocardi
infarct
kegg
pathway
cancer
presenc
cardiac
dysfunct
subject
affect
dmd
common
consid
presenc
enrich
cancer
pathway
also
kegg
glioma
network
result
enrich
consequ
bia
introduc
high
number
gene
annot
cancer
pathway
inde
notic
gene
cancer
pathway
also
belong
enrich
gene
set
tabl
conclus
studi
present
new
bioinformat
workflow
base
biomark
identif
network
analysi
use
extract
biolog
insight
proteom
data
obtain
cohort
dmd
subject
control
methodolog
allow
us
identifi
differ
pathway
deregul
diseas
pinpoint
put
role
foxo
signal
dmd
one
limit
studi
lack
valid
biomark
panel
classif
perform
use
second
independ
cohort
subject
partial
address
issu
avoid
overfit
train
algorithm
comput
biomark
accord
crossvalid
scheme
also
use
second
dataset
differ
natur
transcript
profil
muscl
unrel
cohort
confirm
end
result
analysi
obtain
substanti
confirm
result
anoth
limit
studi
form
silico
analysi
reli
entir
observ
data
therefor
result
valid
mean
function
studi
despit
limit
workflow
deriv
strength
converg
multipl
type
evid
independ
experi
cross
exist
knowledg
biolog
diseas
dataset
analyz
studi
obtain
collabor
somalog
includ
subject
previous
analyz
hathout
cowork
present
dataset
consist
subject
affect
dmd
healthi
agematch
volunt
ppmdc
cohort
group
patient
includ
individu
treat
steroid
subject
proteom
profil
obtain
use
somascan
technolog
somalog
briefli
high
throughput
method
base
use
aptam
high
affin
protein
presenc
aptam
dna
sequenc
allow
quantif
protein
level
simpl
way
use
microarraybas
technolog
detail
cohort
proteom
assay
obtain
origin
studi
approv
cincinnati
children
hospit
medic
center
institut
review
board
inform
consent
obtain
patient
parent
legal
guardian
method
perform
accord
relev
guidelin
regul
protein
biomark
identifi
mean
enhanc
version
rankbas
classif
method
previous
introduc
briefli
preliminari
protein
select
phase
base
wilcoxon
test
classif
method
rank
filter
protein
express
level
separ
sampl
produc
set
subjectspecif
signatur
signatur
list
first
last
protein
rank
valu
subject
paramet
estim
method
alltoal
signatur
comparison
carri
use
distanc
metric
base
weight
enrich
score
result
distanc
matrix
systemat
quantifi
degre
similar
subject
subject
classifi
algorithm
two
group
control
diseas
assign
sampl
group
subject
whose
element
lowest
averag
distanc
sampl
final
protein
biomark
extract
collect
protein
includ
least
one
subjectspecif
signatur
therefor
protein
includ
biomark
requir
comput
correspond
subject
classif
enhanc
version
use
origin
classif
method
extend
previou
studi
genet
optim
automat
select
method
paramet
signatur
length
featur
select
stringenc
find
best
compromis
biomark
length
classif
accuraci
particular
two
biomark
herein
present
provid
shortest
longest
protein
list
allow
classif
accuraci
close
case
longest
biomark
protein
level
also
preprocess
emphas
express
foldchang
divid
protein
level
averag
valu
dataset
avoid
overfit
consid
case
algorithm
train
accord
crossvalid
scheme
subject
set
asid
valid
round
remain
one
use
train
set
determin
biomark
moreov
also
evalu
statist
signific
analysi
mean
permut
test
compar
observ
classif
accuraci
method
empir
distribut
accuraci
valu
obtain
random
permut
protein
label
result
permut
test
obtain
case
pvalu
linear
regress
run
identifi
protein
biomark
panel
associ
age
scale
data
furthermor
presenc
treatment
effect
protein
level
test
use
wilcoxon
test
analys
pvalu
adjust
multipl
test
correct
use
benjaminihochberg
procedur
tissu
specif
evalu
use
transcriptom
data
human
protein
atla
http
wwwproteinatlasorg
databas
protein
classifi
tissu
enrich
mrna
level
one
tissu
least
five
time
higher
tissu
group
enrich
mrna
level
group
tissu
least
five
time
higher
tissu
tissu
enhanc
mrna
level
particular
tissu
least
five
time
averag
level
tissu
express
mrna
detect
tissu
mix
detect
subset
tissu
express
markedli
elev
detect
evalu
enrich
particular
tissu
perform
fisher
exact
test
compar
tissu
enrich
protein
biomark
panel
entir
somalog
panel
perform
gene
set
enrich
analysi
download
gene
set
molecular
signatur
databas
websit
updat
januari
particular
follow
gene
set
collect
investig
hallmark
biocarta
http
wwwbiocartacom
kegg
reactom
hallmark
refin
collect
defin
msigdb
deriv
multipl
founder
point
relev
inform
biolog
condit
avoid
redund
enrich
evalu
use
somalog
panel
background
statist
signific
test
use
hypergeometr
distribut
phyper
function
implement
r
softwar
explor
interact
among
protein
biomark
panel
identifi
put
regul
appli
nasfind
tool
recent
develop
analyz
connect
among
gene
interest
upstream
regul
briefli
protein
biomark
panel
map
refer
proteinprotein
interact
network
human
signal
network
wang
lab
http
wwwcancersystemsbiologyorgdataandsoftwarehtm
subnetwork
connect
protein
interest
case
protein
biomark
panel
closest
transcript
factor
molecul
select
regul
defin
protein
interest
present
refer
network
ad
possibl
biogrid
detail
path
connect
transcript
factor
biomark
protein
establish
nasfind
preferenti
differenti
express
protein
identifi
studi
use
bioconductor
packag
limma
specif
protein
select
signific
show
benjaminihochberg
adjust
pvalu
less
comparison
dmd
subject
control
subnetwork
identifi
evalu
overlap
refer
pathway
kegg
reactom
biocarta
hallmark
collect
msigdb
geneset
enrich
analysi
signific
overlap
calcul
use
onesid
fisher
exact
test
degre
overlap
among
pathway
identifi
nasfind
visual
use
cytoscap
app
enrich
map
run
use
cytoscap
enrich
map
run
use
default
paramet
overlap
coeffici
measur
similar
networkbas
proxim
analysi
dmd
pathway
gene
perform
r
packag
igraph
use
proteinprotein
interact
network
human
protein
refer
databas
hprd
background
network
prefer
signal
network
use
identif
pathway
regul
includ
physic
interact
among
protein
instead
regulatori
interact
pathway
shortest
path
dmd
gene
calcul
shortest
path
distanc
defin
minim
distanc
found
assess
signific
select
random
gene
calcul
minim
shortest
distanc
pathway
thu
obtain
empir
distribut
use
calcul
proport
sampl
minim
shortest
distanc
less
equal
distanc
obtain
use
dmd
dataset
download
ncbi
geo
use
r
bioconductor
packag
geoqueri
dataset
obtain
measur
rna
express
quadricep
biopsi
includ
dmd
patient
control
dmd
biopsi
young
male
show
clinic
symptom
consist
dmd
diagnosi
biopsi
shown
dystrophin
defici
immunofluoresc
andor
western
blot
purpos
studi
analyz
data
platform
includ
control
case
dataset
includ
express
profil
skelet
muscl
children
presymptomat
phase
duchenn
muscular
dystrophi
control
analysi
differenti
express
gene
perform
r
bioconductor
packag
limma
geneset
enrich
analysi
perform
use
msigdb
tool
gsea
packag
http
wwwbroadinstituteorggseamsigdbindexjsp
queri
gene
set
collect
use
network
analysi
obtain
hallmark
kegg
biocarta
reactom
